pyridinolcarbamate has been researched along with Liver Cirrhosis in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Excerpt | Relevance | Reference |
---|---|---|
" The patient received since four years pyridinolcarbamate (Prodectin) because of obliterating peripheral arteriosclerosis." | 3.67 | [Pyridimocarbamate (prodectin)-induced acute liver damage, cirrhosis and primary liver cancer--accidental finding?]. ( Kendrey, G; Kiss, F; László, B, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kendrey, G | 1 |
Kiss, F | 1 |
László, B | 1 |
1 other study available for pyridinolcarbamate and Liver Cirrhosis
Article | Year |
---|---|
[Pyridimocarbamate (prodectin)-induced acute liver damage, cirrhosis and primary liver cancer--accidental finding?].
Topics: Acute Disease; Arteriosclerosis; Carbamates; Chemical and Drug Induced Liver Injury; Female; Humans; | 1989 |